Treatment decisions in multiple sclerosis — insights from real-world observational studiesMaría Trojano, Helmut Butzkueven, Mar Tintoré et al.|Nature Reviews Neurology|2017Cited by 191
Aggressive multiple sclerosis (1): Towards a definition of the phenotypeEllen Iacobaeus, Emmanuelle Waubant, Georgina Arrambide et al.|Multiple Sclerosis Journal|2020Cited by 79
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M. Peeters, Nick Rijke, Tina Parciak et al.|Multiple Sclerosis Journal|2020Cited by 63
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Stella Hughes et al.|JAMA Neurology|2023Cited by 62
Updated Results of the COVID-19 in MS Global Data Sharing InitiativeSteve Simpson, Liesbet M. Peeters, Ashkan Pirmani et al.|Neurology Neuroimmunology & Neuroinflammation|2022Cited by 53